Search the website

Search results

4759 results

Sort by

List item

Advice on implementing measures under Article 57(4) of Regulation (EU) 2019/6 on veterinary medicinal products - Report on the format of the data to be collected on antimicrobial medicinal products used in animals (PDF/655.39 KB) (new)

First published: 08/07/2020
EMA/CVMP/586518/2019
List item

Advice on implementing measures under Article 95(8) of Regulation (EU) 2019/6 on veterinary medicinal products - Good distribution practices (GDP) for active substances used as starting materials in veterinary medicinal products (PDF/332.13 KB) (new)

First published: 08/07/2020
EMA/87754/2020
List item

Advice on implementing measures under Article 99(6) of Regulation (EU) 2019/6 on veterinary medicinal products - Good distribution practices (GDP) for veterinary medicinal products (PDF/441.79 KB) (new)

First published: 08/07/2020
EMA/567192/2019
List item

Opinion of the CVMP on the establishment of maximum residue limits: Ketoprofen (PDF/139.48 KB) (new)

First published: 06/07/2020
EMA/CVMP/94867/2020
List item

Ketoprofen (Bovine, Porcine and Equidae): European public maximum-residue-limit assessment report (EPMAR) - CVMP (PDF/273.06 KB) (new)

Adopted
First published: 02/07/2020
EMA/CVMP/94885/2020
List item

CVMP strategy on antimicrobials 2021-2025 (PDF/325.1 KB) (new)

Draft: consultation open
First published: 01/07/2020
Consultations dates: from 01/07/2020 to 30/09/2020
EMA/CVMP/179874/2020
List item

Leuprorelin-containing depot medicines Article-31 referral - Timetable for the implementation of the CMDh position (PDF/41.34 KB) (new)

First published: 26/06/2020
List item

Leuprorelin-containing depot medicines Article-31 referral - New measures to avoid handling errors with leuprorelin depot medicines (PDF/126.97 KB) (new)

First published: 26/06/2020
EMA/330921/2020
List item

Questions and answers on management of extraneous agents in immunological veterinary medicinal products (IVMPs) (PDF/187.75 KB) (new)

First published: 26/06/2020
EMA/CVMP/IWP/669993/2019
List item

Tulissin : EPAR - Public assessment report (PDF/310.01 KB) (new)

Adopted
First published: 26/06/2020
EMA/94821/2020
List item

Leuprorelin-containing depot medicinal products: new measures to avoid handling errors with leuprorelin depot medicines (PDF/126.97 KB) (new)

First published: 26/06/2020
EMA/330921/2020
List item

Tulaven : EPAR - Public assessment report (PDF/305.44 KB) (new)

Adopted
First published: 26/06/2020
EMA/94834/2020
List item

Minutes of the CVMP meeting of 18-20 May 2020 (PDF/266.05 KB) (new)

Adopted
First published: 26/06/2020
EMA/CVMP/326595/2020
List item

Monthly report on application procedures, guidelines and related documents for veterinary medicines: May 2020 (PDF/240.34 KB) (new)

Adopted
First published: 23/06/2020
EMA/298881/2020
List item

Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 June 2020 (PDF/163.73 KB) (new)

First published: 19/06/2020
EMA/CVMP/302233/2020
List item

CVMP post-authorisation summary of positive opinion for Bluevac BTV (PDF/127.82 KB) (new)

Adopted
First published: 19/06/2020
EMA/CVMP/307513/2020
List item

Bupivacaine - Summary opinion of the CVMP on the establishment of maximum residue limits (PDF/121.83 KB) (new)

Adopted
First published: 19/06/2020
EMA/CVMP/278195/2020
List item

Press release: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 June 2020

CVMP, Last updated: 19/06/2020
List item

Agenda - CVMP agenda of the 16-18 June 2020 meeting (PDF/291.71 KB) (new)

Draft
First published: 16/06/2020
EMA/321774/2020
List item

Report on veterinary medicinal products regarding good pharmacovigilance practice (PDF/451.17 KB) (new)

First published: 12/06/2020
EMA/CVMP/111028/2020
List item

Report on veterinary medicinal products regarding the pharmacovigilance system master file (PDF/235.39 KB) (new)

First published: 12/06/2020
EMA/CVMP/123178/2019
List item

Work plan for the Committee for Medicinal Products for Veterinary Use (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2020 (PDF/171.08 KB)

First published: 04/06/2020
EMA/CVMP/PhVWP/347895/2019
List item

Monthly report on application procedures, guidelines and related documents for veterinary medicines: April 2020 (PDF/247.17 KB)

Adopted
First published: 04/06/2020
EMA/249657/2020
List item

Minutes of the CVMP meeting of 21-23 April 2020 (PDF/313.49 KB)

Adopted
First published: 29/05/2020
EMA/CVMP/271198/2020
List item

Bovine casein hydrolysate : Summary of assessment undertaken to determine whether the substance may be entered into the list of biological substances considered as not requiring an MRL evaluation (PDF/123.84 KB)

Adopted
First published: 29/05/2020
EMA/2278/2020

4759 results

Advice on implementing measures under Article 57(4) of Regulation (EU) 2019/6 on veterinary medicinal products - Report on the format of the data to be collected on antimicrobial medicinal products used in animals (PDF/655.39 KB) (new)

Advice on implementing measures under Article 95(8) of Regulation (EU) 2019/6 on veterinary medicinal products - Good distribution practices (GDP) for active substances used as starting materials in veterinary medicinal products (PDF/332.13 KB) (new)

Advice on implementing measures under Article 99(6) of Regulation (EU) 2019/6 on veterinary medicinal products - Good distribution practices (GDP) for veterinary medicinal products (PDF/441.79 KB) (new)

Opinion of the CVMP on the establishment of maximum residue limits: Ketoprofen (PDF/139.48 KB) (new)

Ketoprofen (Bovine, Porcine and Equidae): European public maximum-residue-limit assessment report (EPMAR) - CVMP (PDF/273.06 KB) (new)

CVMP strategy on antimicrobials 2021-2025 (PDF/325.1 KB) (new)

Leuprorelin-containing depot medicines Article-31 referral - Timetable for the implementation of the CMDh position (PDF/41.34 KB) (new)

Leuprorelin-containing depot medicines Article-31 referral - New measures to avoid handling errors with leuprorelin depot medicines (PDF/126.97 KB) (new)

Questions and answers on management of extraneous agents in immunological veterinary medicinal products (IVMPs) (PDF/187.75 KB) (new)

Tulissin : EPAR - Public assessment report (PDF/310.01 KB) (new)

Leuprorelin-containing depot medicinal products: new measures to avoid handling errors with leuprorelin depot medicines (PDF/126.97 KB) (new)

Tulaven : EPAR - Public assessment report (PDF/305.44 KB) (new)

Minutes of the CVMP meeting of 18-20 May 2020 (PDF/266.05 KB) (new)

Monthly report on application procedures, guidelines and related documents for veterinary medicines: May 2020 (PDF/240.34 KB) (new)

Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 June 2020 (PDF/163.73 KB) (new)

CVMP post-authorisation summary of positive opinion for Bluevac BTV (PDF/127.82 KB) (new)

Bupivacaine - Summary opinion of the CVMP on the establishment of maximum residue limits (PDF/121.83 KB) (new)

Press release: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 16-18 June 2020

Agenda - CVMP agenda of the 16-18 June 2020 meeting (PDF/291.71 KB) (new)

Report on veterinary medicinal products regarding good pharmacovigilance practice (PDF/451.17 KB) (new)

Report on veterinary medicinal products regarding the pharmacovigilance system master file (PDF/235.39 KB) (new)

Work plan for the Committee for Medicinal Products for Veterinary Use (CVMP) Pharmacovigilance Working Party (PhVWP-V) 2020 (PDF/171.08 KB)

Monthly report on application procedures, guidelines and related documents for veterinary medicines: April 2020 (PDF/247.17 KB)

Minutes of the CVMP meeting of 21-23 April 2020 (PDF/313.49 KB)

Bovine casein hydrolysate : Summary of assessment undertaken to determine whether the substance may be entered into the list of biological substances considered as not requiring an MRL evaluation (PDF/123.84 KB)